Medicolegal implications of anticoagulant treatments.

被引:0
|
作者
Samama, M
Valdes, JC
Natali, J
机构
关键词
malpractice; medico-legal medicine; anticoagulant therapy; heparin induced thrombopenia;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Several types of accidents related to anticoagulant treatment can lead to legal procedures, including : thromboembolic post-operative complications associated with lack of anticoagulant prophylaxis and leading to sequelae or death; severe hemorrhagic or thromboembolic accidents attributed to poor management of anticoagulant therapy; complications with sequelae or death resulting from heparin-induced thrombopenia, either with standard or low-molecular weight heparin and associated with poor surveillance of platelet counts. The exceptional nature of accidents leading to legal procedures (74 legal cases in Pr Natali's experience) and the small number of other cases reported should not lead to underestimating the importance of precise rules for anticoagulation treatments. In 7 cases, there was no anticoagulant prophylaxis after surgery. Recent consensus conferences have proposed a definition of small, moderate or high risk of thrombosis as a function of patient status and surgical procedure. Expert working groups have defined the operated patients for which pharmacological anti-coagulation is necessary. In 19 other eases, management of the treatment protocol was insufficient lending to severe hemorrhage with sequelae, severe thromboembolism, or late diagnosis of heparin-induced thrombocytopenia because of insufficient surveillance of platelet counts. Recent advances in laboratory tests far the diagnosis of heparin-induced thrombocytopenia should be emphasized. To these case reports can be added other observations in a small number of complaints resulting from unadvisable treatment combinations, poor surveillance of a thromboembolic event or dangerous invasive exploration.
引用
收藏
页码:250 / 255
页数:6
相关论文
共 50 条
  • [1] ANTISTATIC TREATMENTS.
    Sello, Stephen B.
    Stevens, Catherine V.
    International Fiber Science and Technology Series, 1984, 2 : 291 - 315
  • [2] Psychosocial treatments.
    el-Guebaly, N
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (11): : 735 - 736
  • [3] Transdermal treatments.
    Aiache, JM
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1997, 46 (07): : 441 - 449
  • [4] Podophyllin in antihelminthic treatments.
    Neumann
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1904, 30 : 171 - 171
  • [5] New immunosuppressive treatments.
    Socié, G
    Thervet, E
    PATHOLOGIE BIOLOGIE, 1999, 47 (08): : 827 - 835
  • [6] ALTERNATIVE PROCESSES AND TREATMENTS.
    Restall, J.E.
    Wood, M.I.
    Materials Science and Technology, 1984, 2 (03) : 225 - 231
  • [7] Measuring the prices of medical treatments.
    Dixon, S
    Roberts, J
    ECONOMIC JOURNAL, 2001, 111 (469): : F133 - F134
  • [8] Measuring the prices of medical treatments.
    de Lissovoy, G
    JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2001, 26 (02) : 464 - 467
  • [9] Measuring the prices of medical treatments.
    Kessler, DP
    JOURNAL OF ECONOMIC LITERATURE, 2000, 38 (03) : 664 - 666
  • [10] EXPERIMENTAL PAVEMENT DELINEATION TREATMENTS.
    Bryden, James E.
    Lorini, Ronald A.
    Research Report - New York State Department of Transportation, Engineering Research and Development Bureau, 1981,